INACTIVATION OF NIAID PROGRAM ANNOUNCEMENT PA-01-055 

RELEASE DATE:  December 2, 2003

NOTICE:  NOT-AI-04-009

National Institute of Allergy and Infectious Diseases (NIAID) 
 (http://www.niaid.nih.gov)

PURPOSE

The Division of AIDS (DAIDS) of the National Institute of Allergy and 
Infectious Diseases (NIAID) announces the closure of Program Announcement, 
PA-01-055, “NEW TECHNOLOGIES FOR HIV AND HIV VACCINE RELATED RESEARCH” that 
appeared in the NIH Guide on February 22, 2001 at 
http://grants.nih.gov/grants/guide/pa-files/PA-01-055.html. 

The final receipt date for applications was September 1, 2003.

The PA solicited applications for novel and innovative research in target 
areas to develop improved technologies for detecting HIV, evaluating immune 
responses to HIV vaccines, and expanding immune function measurements; and 
utilizing novel technologies to measure and correlate immune responses that 
are associated with efficacy of licensed non-HIV vaccines.  At this time 
investigator-initiated research in these areas is still strongly encouraged 
through R01 applications.  

INQUIRES

Program Officers in the Vaccine Clinical Research Branch are available to 
offer advice and assistance on anticipated applications.  Contact them by 
calling (301) 496-8379 or through the NIAID/DAIDS 
website, http://www.niaid.nih.gov/daids/.   

At any time, potential applicants can obtain a current listing of active 
NIAID PAs on the NIAID WWW site at URL: 
http://www3.niaid.nih.gov/about/organization/daids/.

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892